evolution of the care of patients with advanced ovarian cancer
IloMerad1
25 views
38 slides
Oct 05, 2024
Slide 1 of 38
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
About This Presentation
cas clinique sur le cancer de l'ovaire avance
Slide Content
Evolution of the Care of Patients With Advanced Ovarian Cancer
Case Study
Case Study
Case Study
Case Study
Polling Question
Rationale for PARP Inhibitor Use in Ovarian Cancer
Mutational Frequency of Non- BRCA HRR Genes
Current Clinical-Grade Genomic Scar Assays to Determine HRD Positivity
Integrated Maintenance Treatment Paradigm for Use in Frontline Ovarian Cancer
Case Study
Integrated Maintenance Treatment Paradigm for Use in Frontline Ovarian Cancer
Case Study
Integrated Maintenance Treatment Paradigm for Use in Frontline Ovarian Cancer
Polling Question
Patient and Disease Characteristics That Influence Treatment Selection
Advanced Ovarian Cancer Options for Maintenance Therapy in HRD-Positive Advanced HGSOC
PRIMA/ENGOT-Ov26/GOG-3012: Niraparib Maintenance PFS: HRD-Positive Disease by BRCA Status
ATHENA-MONO: Rucaparib Maintenance PFS: HRD-Positive Disease
ATHENA-MONO: Rucaparib Maintenance Interim OS Update
PAOLA-1: Bevacizumab + Olaparib Maintenance OS: HRD-Positive Disease
Bevacizumab + PARP Inhibitor Maintenance Does Choice of PARP Inhibitor Matter?
Bevacizumab + PARP Inhibitor Maintenance OVARIO: Niraparib + Bevacizumab
Polling Question
Advanced Ovarian Cancer Options for Maintenance Therapy in HRP Advanced HGSOC
What Do the Guidelines Say? NCCN Guidelines in Ovarian Cancer v1.2024
NCCN Guidelines in Ovarian Cancer v1.2024 Principles of Systemic Therapy
Case Study
Polling Question
PARP Inhibitor Characteristics Inform Treatment Choices
Most Common All-Grade Adverse Events With PARP Inhibitors in Advanced Ovarian Cancer
Niraparib Dosing Considerations Individualized Starting Dose
Olaparib and Rucaparib Dosing Considerations
Monitoring Patients on Oral Therapy Niraparib
Monitoring Patients on Oral Therapy Olaparib and Rucaparib
Pearls for Patient Counseling
Download
Download Slideshow Get the original presentation fileQuick Actions
Statistics
- Views 25
- Slides 38
- Age 441 days
Related Slideshows
36
Clinical approach Dyspnoea A simple and practical approach.pptx
ShajahanPS
39 views
238
Cancer Awareness therapy for public by Dr Kanhu Charan Patro
kanhucpatro
38 views
41
Prof Satyadas Memorial oration Kozhikode.pptx
ShajahanPS
34 views
26
Viral Conjunctivitis and it;s managment.pptx
ZaidAzhar
46 views
30
Essential Thrombocythemia 15 Years of Experience at the Hematology Department, Algies, Algeria.pdf
sbelakehal
40 views
10
Hypertension sign symptoms cmdt style with regime
androiddabest
41 views